Antibody and other COVID-19 treatments are effective and available

March 24, 2022

The spectrum of medical therapies to treat COVID-19 continues to evolve and address SARS-CoV-2 variants. Sotrovimab, Tixagevimab/Cilgavimab (Evusheld), Bebtelovimab, Paxlovid and Molnupiravir are therapeutic products available that have received Emergency Use Authorizations (EUAs) from the Food and Drug Administration (FDA) and available to providers in our state.

All therapeutics can be requested via the COVID-19 Therapeutic Allocation Request Form. Sites must have a Healthcare Partner Ordering Portal (HPOP) account to receive shipments. HPOP accounts need to have therapeutic address/hours verified in order to receive product and must report on-hand and dispensed product daily.

For questions related to therapeutics, please reach out to the Washington State Department of Health Medical Countermeasure Team at


Contact Us

Washington State Hospital Association
999 Third Avenue
Suite 1400
Seattle, WA 98104

Map / Directions

206.281.7211 phone
206.283.6122 fax

Staff List